November 9, 2026
Explore Our Latest News
Stay Up to Date on the Breakthroughs and Events Shaping the Future of Radiopharmaceuticals
Press Releases
December 16, 2025
PharmaLogic Announces Successful Supply of First Cohort Dosing for Ratio Therapeutics’ Phase 1/2 Study of a Novel FAP-Targeted Radiopharmaceutical in Late-Stage Aggressive Sarcomas
ReadJune 2, 2025
PharmaLogic Announces Appointment of Etienne Montagut as President and Chief Executive Officer
ReadApril 9, 2025
PharmaLogic to Acquire Majority Stake in Agilera, Strengthening Global Expertise in Radiopharmaceutical Therapeutics
ReadOctober 29, 2024